Search Results - "CATALIOTTI, Alessandro"

Conflicting vascular and metabolic impact of the IL-33/sST2 axis by Altara, Raffaele, Ghali, Rana, Mallat, Ziad, Cataliotti, Alessandro, Booz, George W, Zouein, Fouad A

“…Abstract Interleukin 33 (IL-33), which is expressed by several immune cell types, endothelial and epithelial cells, and fibroblasts, is a cytokine of the IL-1…”
Get full text

Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes by Kolstad, Terje R, van den Brink, Jonas, MacQuaide, Niall, Lunde, Per Kristian, Frisk, Michael, Aronsen, Jan Magnus, Norden, Einar S, Cataliotti, Alessandro, Sjaastad, Ivar, Sejersted, Ole M, Edwards, Andrew G, Lines, Glenn Terje, Louch, William E

“…Reduced cardiac contractility during heart failure (HF) is linked to impaired Ca 2+ release from Ryanodine Receptors (RyRs). We investigated whether this…”
Get full text

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics by Mangiafico, Sarah, Costello-Boerrigter, Lisa C, Andersen, Ingrid A, Cataliotti, Alessandro, Burnett, Jr, John C

“…Hypertension and heart failure (HF) are common diseases that, despite advances in medical therapy, continue to be associated with high morbidity and mortality…”
Get full text

Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques by Tombolesi, Niki, Altara, Raffaele, da Silva, Gustavo J. J., Tannous, Cynthia, Zouein, Fouad A., Stensløkken, Kåre-Olav, Morresi, Assunta, Paolantoni, Marco, Booz, George W., Cataliotti, Alessandro, Sassi, Paola

“…The pathophysiology of heart failure with preserved ejection fraction (HFpEF) is a matter of investigation and its diagnosis remains challenging. Although the…”
Get full text

Vibrational spectroscopy identifies myocardial chemical modifications in heart failure with preserved ejection fraction by Pioppi, Leonardo, Parvan, Reza, Samrend, Alan, Silva, Gustavo Jose Justo, Paolantoni, Marco, Sassi, Paola, Cataliotti, Alessandro

“…Abstract Background Vibrational spectroscopy can be a valuable tool to monitor the markers of cardiovascular diseases. In the present work, we explored the…”
Get full text

Seasonal variations of hyponatremia in the emergency department: Age-related changes by Giordano, Mauro, MD, Ciarambino, Tiziana, MD, Castellino, Pietro, MD, Malatino, Lorenzo, MD, Cataliotti, Alessandro, MD, Rinaldi, Luca, MD, Paolisso, Giuseppe, MD, Adinolfi, Luigi Elio, MD

“…Abstract Study objective We investigated seasonal prevalence of hyponatremia in the emergency department (ED). Design A cross-sectional study using clinical…”
Get full text

Atrial Natriuretic Peptide31–67: A Novel Therapeutic Factor for Cardiovascular Diseases by da Silva, Gustavo Jose Justo, Altara, Raffaele, Booz, George W., Cataliotti, Alessandro

“…The characterization of the cardiac hormone atrial natriuretic peptide (ANP 9 9 – 1 26 ), synthesized and secreted predominantly by atrial myocytes under…”
Get full text

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP by Macheret, Fima, MD, MS, Heublein, Denise, CLT, Costello-Boerrigter, Lisa C., MD, PhD, Boerrigter, Guido, MD, McKie, Paul, MD, Bellavia, Diego, MD, Mangiafico, Sarah, MD, Ikeda, Yasuhiro, MD, DVM, Bailey, Kent, PhD, Scott, Christopher G., MS, Sandberg, Sharon, CLT, Chen, Horng H., MD, Malatino, Lorenzo, MD, Redfield, Margaret M., MD, Rodeheffer, Richard, MD, PhD, Burnett, John, MD, Cataliotti, Alessandro, MD, PhD

“…Objectives This study sought to investigate plasma levels of circulating cardiac natriuretic peptides, atrial natriuretic peptide (ANP) and B-type or brain…”
Get full text

The Prognostic Value of N-Terminal Pro–B-Type Natriuretic Peptide for Death and Cardiovascular Events in Healthy Normal and Stage A/B Heart Failure Subjects by McKie, Paul M., MD, Cataliotti, Alessandro, MD, PhD, Lahr, Brian D., MS, Martin, Fernando L., MD, Redfield, Margaret M., MD, Bailey, Kent R., PhD, Rodeheffer, Richard J., MD, Burnett, John C., MD

“…Objectives Our objective was to determine the prognostic value of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) for death and cardiovascular…”
Get full text

Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression by Røe, Åsmund T, Ruud, Marianne, Espe, Emil K, Manfra, Ornella, Longobardi, Stefano, Aronsen, Jan M, Nordén, Einar Sjaastad, Husebye, Trygve, Kolstad, Terje R S, Cataliotti, Alessandro, Christensen, Geir, Sejersted, Ole M, Niederer, Steven A, Andersen, Geir Øystein, Sjaastad, Ivar, Louch, William E

“…Abstract Aims Regional heterogeneities in contraction contribute to heart failure with reduced ejection fraction (HFrEF). We aimed to determine whether…”
Get full text

FTIR Analysis of Renal Tissue for the Assessment of Hypertensive Organ Damage and proANP31–67 Treatment by Pioppi, Leonardo, Tombolesi, Niki, Parvan, Reza, da Silva, Gustavo Jose Justo, Altara, Raffaele, Paolantoni, Marco, Morresi, Assunta, Sassi, Paola, Cataliotti, Alessandro

“…The kidneys are one of the main end organs targeted by hypertensive disease. Although the central role of the kidneys in the regulation of high blood pressure…”
Get full text

Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study by Røsjø, Helge, Dahl, Mai Britt, Jørgensen, Marit, Røysland, Ragnhild, Brynildsen, Jon, Cataliotti, Alessandro, Christensen, Geir, Høiseth, Arne Didrik, Hagve, Tor-Arne, Omland, Torbjørn

“…The N-terminal part of pro-B-type natriuretic peptide (NT-proBNP) is glycosylated, but whether glycosylation influences the diagnostic and prognostic accuracy…”
Get full text

Novel Protein Therapeutics for Systolic Heart Failure by Chen, Horng H., MB, BCh, Glockner, James F., MD, Schirger, John A., MD, Cataliotti, Alessandro, MD, PhD, Redfield, Margaret M., MD, Burnett, John C., MD

“…Objectives The purpose of the present study was to translate our laboratory investigations to establish safety and efficacy of 8 weeks of chronic SC B-type…”
Get full text

Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction by Altara, Raffaele, Giordano, Mauro, Nordén, Einar S, Cataliotti, Alessandro, Kurdi, Mazen, Bajestani, Saeed N, Booz, George W

“…Heart failure with preserved ejection fraction (HFpEF) is a major unmet medical need that is characterized by the presence of multiple cardiovascular and…”
Get full text

Long-term effects of moderate protein diet on renal function and low-grade inflammation in older adults with type 2 diabetes and chronic kidney disease by Giordano, Mauro, M.D., Ph.D, Ciarambino, Tiziana, M.D, Castellino, Pietro, M.D, Cataliotti, Alessandro, M.D, Malatino, Lorenzo, M.D, Ferrara, Nicola, M.D, Politi, Cecilia, M.D, Paolisso, Giuseppe, M.D

“…Abstract Objectives The aim of this study was to determine the long-term effects of a moderate protein diet (MPD) on renal function, low-grade inflammation,…”
Get full text

Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression by Zoccali, Carmine, Benedetto, Francesco A., Mallamaci, Francesca, Tripepi, Giovanni, Giacone, Giuseppe, Stancanelli, Benedetta, Cataliotti, Alessandro, Malatino, Lorenzo S.

“…Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression. Regression of left…”
Get full text

A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community by Cannone, Valentina, MD, PhD, Boerrigter, Guido, MD, Cataliotti, Alessandro, MD, PhD, Costello-Boerrigter, Lisa C., MD, PhD, Olson, Timothy M., MD, McKie, Paul M., MD, Heublein, Denise M., CLT, Lahr, Brian D., MS, Bailey, Kent R., PhD, Averna, Maurizio, MD, PhD, Redfield, Margaret M., MD, Rodeheffer, Richard J., MD, Burnett, John C., MD

“…Objectives We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. Background…”
Get full text

Quantitative Mass Spectral Evidence for the Absence of Circulating Brain Natriuretic Peptide (BNP-32) in Severe Human Heart Failure by Adam M. Hawkridge, Denise M. Heublein, H. Robert Bergen III, Alessandro Cataliotti, John C. Burnett, Jr, David C. Muddiman, Fenn, John B.

“…C-terminal brain (B-type) natriuretic peptide (BNP)-32 is a widely used clinical biomarker for the diagnosis, prognosis, and treatment of heart failure (HF)…”
Get full text

Long-Term Cardiac pro-B-Type Natriuretic Peptide Gene Delivery Prevents the Development of Hypertensive Heart Disease in Spontaneously Hypertensive Rats by CATALIOTTI, Alessandro, TONNE, Jason M, BURNETT, John C, IKEDA, Yasuhiro, BELLAVIA, Diego, MARTIN, Fernando L, OEHLER, Elise A, HARDERS, Gerald E, CAMPBELL, Jarryd M, PENG, Kaw-Whye, RUSSELL, Stephen J, MALATINO, Lorenzo S

“…Diastolic dysfunction associated with high blood pressure (BP) leads to cardiac remodeling and fibrosis and progression to congestive heart failure. B-type…”
Get full text

Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection by Martin, Fernando L, McKie, Paul M, Cataliotti, Alessandro, Sangaralingham, S Jeson, Korinek, Josef, Huntley, Brenda K, Oehler, Elise A, Harders, Gerald E, Ichiki, Tomoko, Mangiafico, Sarah, Nath, Karl A, Redfield, Margaret M, Chen, Horng H, Burnett, Jr, John C

“…Impaired renal function with loss of nephron number in chronic renal disease (CKD) is associated with increased cardiovascular morbidity and mortality…”
Get more information